David Hong, MD
Disclosures: Consulting Fee-Current-Alpha Insights|Consulting Fee-Current-Amgen|Consulting Fee-Current-Axiom|Consulting Fee-Current-Adaptimmune|Consulting Fee-Current-Baxter International, Inc.|Consulting Fee-Current-Bayer Corporation|Consulting Fee-Current-Genentech, Inc.|Consulting Fee-Current-GLG|Consulting Fee-Current-Group H|Consulting Fee-Current-Guidepoint|Consulting Fee-Current-Infinity|Consulting Fee-Current-Janssen|Consulting Fee-Current-Merrimack|Consulting Fee-Current-Medscape|Consulting Fee-Current-Numab|Consulting Fee-Current-Pfizer, Inc.|Consulting Fee-Current-Prime Oncology|Consulting Fee-Current-Seattle Genetics|Consulting Fee-Current-Takeda Pharmaceuticals, Inc.|Consulting Fee-Current-Trieza Therapeutics|Consulting Fee-Current-WebMD|Ownership Interest-Current-Molecular Match|Ownership Interest-current-OncoResponse|Contracted Research-current-Abbvie|Contracted Research-current-Adaptimmune|Contracted Research-Current-Aldi-Norte|Contracted Research-Current-Amgen|Contracted Research-Current-AstraZeneca|Contracted Research-Current-Daiichi Sankyo|Contracted Research-current-Eisai, Inc.|Contracted Research-Current-Fate Therapeutics|Contracted Research-Current-Genentech, Inc.|Contracted Research-Current-Genmab|Contracted Research-Current-Ignyta|Contracted Research-current-Infinity|Contracted Research-current-Kite|Contracted Research-Current-Kyowa|Contracted Research-current-Lilly|Contracted Research-Current-LOXO|Contracted Research-Current-Merck and Company, Inc.|Contracted Research-current-Medimmune|Contracted Research-current-Mirati|Contracted Research-Current-miRNA|Contracted Research-Current-Molecular Templates|Contracted Research-Current-Mologen|Contracted Research-Current-NCI-CTEP|Contracted Research-Current-Novartis|Contracted Research-Current-Seattle Genetics|Contracted Research-Current-Takeda Pharmaceuticals, Inc.|Contracted Research-Current-Turning Point Therapeutics|Contracted Research-Current-Pfizer, Inc.|Ownership Interest-Current-Presagia Inc.
No Bio Available.